NEWS

November 7, 2018
On OrthoMedex’s 3rd year anniversary, it is pleased to announce the issuance of its 3rd USPTO Patent # 10,117,973, entitled: Methods of Using Water-Soluble Inorganic Compounds for Implants.
Read more
September 9, 2018
OrthoMedex LLC is pleased to announce its successful completion of Connecticut’s first state sponsored Bioscience Accelerator – ABCT.
Read more
August 20, 2018
OrthoMedex is pleased to announce that its international research collaboration with the Medical Valley was highlighted in the GTAI journal – MARKETS.
Read more

February 2, 2018
​OrthoMedex LLC Selected for Connecticut’s First Bioscience Accelerator
​Read more

November 13, 2017
OrthoMedex LLC Announces the Formation of OrthoMedex GmbH
Read More
October 25, 2017
OrthoMedex LLC Presents at OktoberINVESTfest 2017
Read More
September 1, 2017
OrthoMedex LLC Announces
Medical Valley EMN E.V. ‘Internationalization’ Grant 
​Read More 
June 19, 2017
OrthoMedex LLC Attends EIT Health’s
‘Go Global’ MedTech Accelerator, and
Pitches At ‘2017 MedTech Summit Conference’
​Read More
 May 18, 2017
OrthoMedex LLC Announces Issuance of USPTO Patent # 9,592,206 and the Publication of USPTO Patent Application # 2017/0136156; Both Entitled:
“Methods of Using Water-Soluble Inorganic Compounds for Implants”
​Read More
 Picture
OrthoMedex LLC is committed to the commercialization of proprietary orthopedic implants and surgical devices that leverage the antimicrobial and osteostimulative attributes of bioactive glass, in order to address the unmet infection control and implant fixation needs of the orthopedic surgeon. 





​

For further information please contact: 

Jim Walls 
Founder & CEO
OrthoMedex LLC
Managing Director 
OrthoMedex GmbH
jim.walls@orthomedex.com
+1.203.393.1387